← Back to Search

Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link for Respiratory Infection

N/A
Waitlist Available
Led By Peter Szilagyi, MD, MPH
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing different ways to remind people to get their flu vaccine. Participants will be randomly assigned to one of three groups: 1) receiving text based reminder messages with a direct link to schedule their vaccine, 2) portal-based reminder messages with a direct link to schedule their vaccine, or 3) the control group. The study will take place at clinics within the UCLA Health System.

Eligible Conditions
  • Influenza
  • Respiratory Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Influenza virus vaccine
Influenza virus vaccine

Trial Design

7Treatment groups
Active Control
Group I: Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule LinkActive Control1 Intervention
Participants in this arm will receive a pre-commitment prompt message by portal in September. Tailored R/R messages will be sent monthly based on time and place selected by patients (up to 3). R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.
Group II: Text Fixed R/R Messages with Direct Appointment Schedule Link + Text Pre-Appointment RemindersActive Control2 Interventions
Participants in this arm will receive up to 3 R/R messages by text. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder via text when they schedule a visit during the study period.
Group III: Text Fixed R/R Messages with Direct Appointment Schedule LinkActive Control1 Intervention
Participants in this arm will receive up to 3 R/R messages by text. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.
Group IV: Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersActive Control2 Interventions
Participants in this arm will receive a pre-commitment prompt message by portal in September. Tailored R/R messages will be sent monthly by portal based on time and place selected by patients (up to 3). R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment via portal when they schedule a visit during the study period.
Group V: Portal Fixed R/R Messages with Direct Appointment Schedule Link + Portal Pre-Appointment ReminderActive Control2 Interventions
Participants in this arm will receive up to 3 R/R messages by portal. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment via portal when they schedule a visit during the study period.
Group VI: Portal Fixed R/R Messages with Direct Appointment Schedule LinkActive Control1 Intervention
Participants in this arm will receive up to 3 R/R messages by portal. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.
Group VII: No R/R Message or Pre-Appointment ReminderActive Control1 Intervention
Participants do not receive any flu vaccine R/R message or Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment during the specified flu season.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,014,766 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,219,047 Total Patients Enrolled
Peter Szilagyi, MD, MPHPrincipal InvestigatorUniversity of California, Los Angeles
2 Previous Clinical Trials
92,423 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining in this clinical investigation?

"Data hosted on clinicaltrials.gov demonstrates that this medical study is no longer actively enrolling patients, as the last update was made on August 30th 2022. Although enrollment has ceased for this particular trial, there are 202 other trials currently looking for volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Patient Portal Flu Vaccine Reminders (5)
Peter G Szilagyi, MD MPH 2022. "Patient Portal Flu Vaccine Reminders (5)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05525494.
~101452 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top